NF1 and malignant peripheral nerve sheath tumor: Evans et al performed a population-based longitudinal study to assess the lifetime risk of developing MPNSTs in NF-1 patients.[7] They reported that 21 NF-1 patients developed MPNST, corresponding to an annual incidence of 1.6 per 1000 and a lifetime risk of 8% to 13%.[7]